GCK, glucokinase, 2645

N. diseases: 210; N. variants: 182
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Our findings suggest a relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 (21 in 28) among Danish kindred clinically diagnosed as MODY. 15928245 2005
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE There are quantitative and qualitative differences in insulin secretory defects which differentiate subjects with MODY due to mutation in the gene on chromosome 20q from those with glucokinase mutations. 8894490 1996
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The p.Leu77Arg but not p.Val101Met GCK mutation is therefore considered a pathogenic mutation associated with MODY. 27185633 2016
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE hs-CRP was lower in HNF1A-MODY (median [IQR] 0.3 [0.1-0.6] mg/L) than type 2 diabetes (1.40 [0.60-3.45] mg/L; P < 0.001) and type 1 diabetes (1.10 [0.50-1.85] mg/L; P < 0.001), HNF4A-MODY (1.45 [0.46-2.88] mg/L; P < 0.001), GCK-MODY (0.60 [0.30-1.80] mg/L; P < 0.001), and HNF1B-MODY (0.60 [0.10-2.8] mg/L; P = 0.07). hs-CRP discriminated HNF1A-MODY from type 2 diabetes with hs-CRP <0.75 mg/L showing 79% sensitivity and 70% specificity (receiver operating characteristic area under the curve = 0.84). 21700917 2011
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Urinary metabolic profiling by Nuclear Magnetic Resonance (NMR) and ultra performance liquid chromatography hyphenated to Q-TOF mass spectrometry (UPLC-MS) was performed in a Discovery set of subjects with HNF1A-MODY (n = 14), GCK-MODY (n = 17), T2D (n = 14) and normoglycaemic controls (n = 34). 22859960 2012
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The majority of patients (27/33, 81.8%) had variants in MODY‑related genes: GCK (n=19), HNF1A (n=2), PAX4 (n=1), ABCC8 (n=1), KCNJ11 (n=1), GCK+HNF1A (n=1), GCK+BLK (n=1) and GCK+BLK+WFS1 (n=1). 31638168 2019
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease CLINVAR GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. 22820548 2012
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Mutations in the glucokinase gene cause a rare form of diabetes called maturity-onset diabetes of the young (MODY). 10347805 1999
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The study included 80 patients with HNF1A-MODY and 89 GCK gene mutation carriers. 30421137 2019
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The level of 1,5-AG was lowest in type 1 diabetes and HNF1A MODY, 3.8 and 4.7 μg/ml, respectively, and highest (11.2 μg/ml) in GCK MODY. 30778899 2019
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The metabolite profiling was confirmed by enzymatic assays and replicated in a cohort of 11 GCK-MODY patients. 23139355 2013
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. 23771925 2013
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease CLINVAR Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase. 29284910 2017
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The biochemical design also suggests certain candidate diabetes genes related to fuel metabolism: low-activity and low-stability GK mutants that explain in part the maturity-onset diabetes of the young (MODY) phenotype in humans and mitochondrial DNA mutations of FoF1 ATPase components thought to cause late-onset diabetes in BHEcdb rats. 8549869 1996
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Heterozygous inactivating mutations in GCK cause maturity-onset diabetes of the young (MODY) subtype glucokinase (GCK), characterized by mild fasting hyperglycemia, which is present at birth but often only detected later in life during screening for other purposes. 19790256 2009
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE In contrast to the glucokinase and HNF-1alpha genes, mutations in the HNF-4alpha gene are a relatively uncommon cause of MODY, and our understanding of the MODY1 form of diabetes is based on studies of only a single family, the R-W pedigree. 9294105 1997
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The aim of the study was to search for mutations in the NEUROD1 and IPF-1 genes in patients with clinical characteristics of maturity-onset diabetes of the young (MODY) but with no mutations in the HNF-4A (MODY1), GCK (MODY2) and TCF1 (MODY3) genes. 18331410 2008
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE The aim of this study was to characterize glucokinase (GCK) alterations in maturity-onset diabetes of the young 2 (MODY2)-suspected patients and to investigate their clinical characteristics in relation to the parental origin of the mutation. 18248649 2008
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Identification of GCK mutations in selected MODY patients was performed by single-strand conformation polymorphism and direct sequencing. 17186219 2007
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. 8168652 1994
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Mutations in the glucokinase gene have been identified recently in patients with maturity-onset diabetes of the young, a subtype of NIDDM. 8325443 1993
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE These include the characterization of mutations in the glucokinase gene in maturity onset diabetes of the young, localization to chromosome 2 of a gene involved in familial colon cancer, and localization to chromosome 19 of a gene responsible for hemiplegic migraine. 7764464 1993
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Pathophysiologically, there are at least two genetically different forms of diabetes linked to energy metabolism: the first example is one form of maturity-onset diabetes of the young (MODY2), an autosomal dominant disorder caused by point mutations of the glucokinase gene; the second example is several forms of mitochondrial diabetes caused by point and length mutations of the mitochondrial DNA (mtDNA) that encodes several subunits of the respiratory chain complexes. 8549853 1996
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Among patients with neonatal diabetes (i.e. with onset within first 6 months of life) and patients with Maturity Onset Diabetes of the Young (MODY; an autosomal dominant form of diabetes), those carrying mutations in KCNJ11, ABCC8, HNF1A and HNF4A genes usually respond to oral therapy with sulphonylurea, while those bearing GCK mutations do not necessitate any treatment. 30086875 2018
Maturity onset diabetes mellitus in young
0.700 GeneticVariation disease BEFREE Mutations in the beta-cell genes encoding the glycolytic enzyme glucokinase (GCK) and the transcription factor hepatocyte nuclear factor (HNF)-1alpha are the most common causes of maturity-onset diabetes of the young (MODY). 11272165 2001